Basics Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases. IPO Date: March 11, 2013 Sector: Healthcare Industry: Biotech Market Cap: $335.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.14% Avg Daily Range (30 D): $0.10 | 3.45% Avg Daily Range (90 D): $0.09 | 3.15% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): 1.56M Avg Daily Volume (90 D): 1.1M Trade Size Avg Trade Size (Sh.): 184 Avg Trade Size (Sh.) (30 D): 183 Avg Trade Size (Sh.) (90 D): 142 Institutional Trades Total Inst.Trades: 281 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $1.19M Avg Inst. Trade (90 D): $1.47M Avg Inst. Trade Volume: .45M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.1M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $1.95M Avg Closing Volume: 505.27K         News May 12, 2025 @ 8:05 PM Savara Announces Participation in the H.C. Wainwri... Source: Business Wire May 1, 2025 @ 8:05 PM Savara Announces Participation in the Upcoming Cit... Source: Business Wire Dec 13, 2024 @ 7:12 AM XChain, VARA’s Exclusive Transaction Monito... Source: Globe Newswire Nov 13, 2024 @ 1:05 PM Savara Announces Participation in Upcoming Healthc... Source: Business Wire Oct 22, 2024 @ 12:05 PM Savara Announces the Rare Lung Disease, Autoimmune... Source: Business Wire Financials   TTM Q4 2024 FY 2024 Basic EPS $-.12 $-.13 $-.48 Diluted EPS $-.12 $-.13 $-.48 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -26.64M $ -29.04M $ -95.88M Operating Income / Loss $ -28.44M $ -31.17M $ -103.2M Cost of Revenue $ $ $ Net Cash Flow $ 4.46M $ -6.23M $ -11.45M PE Ratio     Splits Apr 28, 2017:   1:70 Apr 26, 2010:   1:25 Jul 26, 2000:   1:2